Media Coverage · January 2, 2015

LABIOTECH.eu: Biotech’s crowdfunding: is France top of the class?

Biotech’s crowdfunding: is France top of the class?

labiotech_eu_logo

By Joachim Eeckhout – Published on December 22, 2014 | LABIOTECH.eu

In France, you can feel a real enthusiasm for crowdfunding and many projects are running on different platforms. I met several companies currently fundraising to understand their reasons and issues. The first of these, Acticor Biotech, develops an antibody inhibitor of arterial thrombosis, directed against the glycoprotein 6 (GP6), a new therapeutic target on the surface of platelets.[…]

Read next in 'Media Coverage'